Last reviewed · How we verify

American ginseng

Johns Hopkins University · FDA-approved active Small molecule

American ginseng contains bioactive compounds (ginsenosides) that modulate immune function, reduce inflammation, and enhance stress resistance through multiple cellular pathways.

American ginseng contains bioactive compounds (ginsenosides) that modulate immune function, reduce inflammation, and enhance stress resistance through multiple cellular pathways. Used for Cancer-related fatigue, General fatigue and stress resistance, Immune support.

At a glance

Generic nameAmerican ginseng
Also known asEfavienz (Sustiva), ginseng, Ginseng Root, Panax quinquifolius, Panax quinquefolius
SponsorJohns Hopkins University
Drug classHerbal adaptogen
ModalitySmall molecule
Therapeutic areaGeneral wellness, fatigue, immunomodulation
PhaseFDA-approved

Mechanism of action

American ginseng (Panax quinquefolius) contains ginsenosides and polysaccharides that act as adaptogens, helping the body resist physical and mental stress. These compounds interact with multiple targets including immune cells, cytokine pathways, and stress hormone regulation. The herb has been studied for immunomodulatory effects, antioxidant activity, and potential benefits in fatigue and cognitive function.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: